ID NPL4_HUMAN Reviewed; 608 AA. AC Q8TAT6; Q8N3J1; Q9H8V2; Q9H964; Q9NWR5; Q9P229; DT 29-MAR-2004, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 27-MAR-2024, entry version 181. DE RecName: Full=Nuclear protein localization protein 4 homolog; DE Short=Protein NPL4; GN Name=NPLOC4; Synonyms=KIAA1499, NPL4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Brain; RX PubMed=10819331; DOI=10.1093/dnares/7.2.143; RA Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XVII. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 7:143-150(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 2-8. RC TISSUE=Platelet; RX PubMed=12665801; DOI=10.1038/nbt810; RA Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., RA Vandekerckhove J.; RT "Exploring proteomes and analyzing protein processing by mass spectrometric RT identification of sorted N-terminal peptides."; RL Nat. Biotechnol. 21:566-569(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 90-608. RC TISSUE=Melanoma; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [6] RP INTERACTION WITH UFD1, AND TISSUE SPECIFICITY. RX PubMed=11574150; DOI=10.1016/s0378-1119(01)00649-7; RA Botta A., Tandoi C., Fini G., Calabrese G., Dallapiccola B., Novelli G.; RT "Cloning and characterization of the gene encoding human NPL4, a protein RT interacting with the ubiquitin fusion-degradation protein (UFD1L)."; RL Gene 275:39-46(2001). RN [7] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP INTERACTION WITH ZFAND2B. RX PubMed=24160817; DOI=10.1042/bj20130710; RA Glinka T., Alter J., Braunstein I., Tzach L., Wei Sheng C., Geifman S., RA Edelmann M.J., Kessler B.M., Stanhill A.; RT "Signal-peptide-mediated translocation is regulated by a p97-AIRAPL RT complex."; RL Biochem. J. 457:253-261(2014). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [11] RP FUNCTION, INTERACTION WITH UFD1 AND VCP, AND MUTAGENESIS OF 6-ILE--ARG-8; RP ARG-17 AND ARG-50. RX PubMed=26471729; DOI=10.15252/embj.201591888; RA Hao Q., Jiao S., Shi Z., Li C., Meng X., Zhang Z., Wang Y., Song X., RA Wang W., Zhang R., Zhao Y., Wong C.C., Zhou Z.; RT "A non-canonical role of the p97 complex in RIG-I antiviral signaling."; RL EMBO J. 34:2903-2920(2015). CC -!- FUNCTION: The ternary complex containing UFD1, VCP and NPLOC4 binds CC ubiquitinated proteins and is necessary for the export of misfolded CC proteins from the ER to the cytoplasm, where they are degraded by the CC proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly CC at the end of mitosis and is necessary for the formation of a closed CC nuclear envelope (By similarity). Acts as a negative regulator of type CC I interferon production via the complex formed with VCP and UFD1, which CC binds to RIGI and recruits RNF125 to promote ubiquitination and CC degradation of RIGI (PubMed:26471729). {ECO:0000250|UniProtKB:Q9ES54, CC ECO:0000269|PubMed:26471729}. CC -!- PATHWAY: Protein degradation; proteasomal ubiquitin-dependent pathway. CC -!- SUBUNIT: Heterodimer with UFD1 (PubMed:11574150, PubMed:26471729). The CC heterodimer binds ubiquitinated proteins (By similarity). The CC heterodimer binds to VCP and inhibits Golgi membrane fusion CC (PubMed:11574150, PubMed:26471729). Interacts with ZFAND2B; probably CC through VCP (PubMed:24160817). {ECO:0000250|UniProtKB:Q9ES54, CC ECO:0000269|PubMed:11574150, ECO:0000269|PubMed:24160817, CC ECO:0000269|PubMed:26471729}. CC -!- INTERACTION: CC Q8TAT6; O95786: RIGI; NbExp=6; IntAct=EBI-1994109, EBI-995350; CC Q8TAT6; P37173: TGFBR2; NbExp=3; IntAct=EBI-1994109, EBI-296151; CC Q8TAT6; Q92890: UFD1; NbExp=8; IntAct=EBI-1994109, EBI-1994090; CC Q8TAT6; P55072: VCP; NbExp=13; IntAct=EBI-1994109, EBI-355164; CC Q8TAT6; Q4G0F5: VPS26B; NbExp=3; IntAct=EBI-1994109, EBI-6151831; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:Q9ES54}. Endoplasmic reticulum CC {ECO:0000250|UniProtKB:Q9ES54}. Nucleus {ECO:0000250|UniProtKB:Q9ES54}. CC Note=Associated with the endoplasmic reticulum and nuclear. CC {ECO:0000250|UniProtKB:Q9ES54}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8TAT6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8TAT6-2; Sequence=VSP_009789; CC -!- TISSUE SPECIFICITY: Expressed at highest levels in brain, heart, CC skeletal muscle, kidney and fetal liver. {ECO:0000269|PubMed:11574150}. CC -!- DOMAIN: Binds ubiquitinated proteins via its RanBP2-type zinc finger. CC {ECO:0000250|UniProtKB:Q9ES54}. CC -!- MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. CC {ECO:0000305}. CC -!- SIMILARITY: Belongs to the NPL4 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA91314.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAA96023.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAB14372.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAB14499.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB040932; BAA96023.1; ALT_INIT; mRNA. DR EMBL; AK000664; BAA91314.1; ALT_INIT; mRNA. DR EMBL; AK023046; BAB14372.1; ALT_INIT; mRNA. DR EMBL; AK023272; BAB14499.1; ALT_INIT; mRNA. DR EMBL; BC025930; AAH25930.1; -; mRNA. DR EMBL; AL834300; CAD38971.1; -; mRNA. DR CCDS; CCDS45812.1; -. [Q8TAT6-1] DR RefSeq; NP_060391.2; NM_017921.3. [Q8TAT6-1] DR RefSeq; XP_011523281.1; XM_011524979.1. [Q8TAT6-2] DR PDB; 7WWP; X-ray; 2.99 A; A=91-560. DR PDB; 7WWQ; X-ray; 2.72 A; A=96-560. DR PDBsum; 7WWP; -. DR PDBsum; 7WWQ; -. DR AlphaFoldDB; Q8TAT6; -. DR SMR; Q8TAT6; -. DR BioGRID; 120798; 218. DR ComplexPortal; CPX-137; VCP-NPL4-UFD1 AAA ATPase complex. DR ComplexPortal; CPX-8096; VCP-NPL4-UFD1-FAF1 AAA ATPase complex. DR ComplexPortal; CPX-8101; VCP-NPL4-UFD1-UBXN7 AAA ATPase complex. DR ComplexPortal; CPX-8104; VCP-NPL4-UFD1-FAF2 AAA ATPase complex. DR ComplexPortal; CPX-8105; VCP-NPL4-UFD1-UBXN1 AAA ATPase complex. DR CORUM; Q8TAT6; -. DR DIP; DIP-44059N; -. DR IntAct; Q8TAT6; 45. DR MINT; Q8TAT6; -. DR STRING; 9606.ENSP00000331487; -. DR TCDB; 3.A.16.1.1; the endoplasmic reticular retrotranslocon (er-rt) family. DR GlyGen; Q8TAT6; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q8TAT6; -. DR PhosphoSitePlus; Q8TAT6; -. DR SwissPalm; Q8TAT6; -. DR BioMuta; NPLOC4; -. DR DMDM; 50428974; -. DR EPD; Q8TAT6; -. DR jPOST; Q8TAT6; -. DR MassIVE; Q8TAT6; -. DR MaxQB; Q8TAT6; -. DR PaxDb; 9606-ENSP00000331487; -. DR PeptideAtlas; Q8TAT6; -. DR ProteomicsDB; 73917; -. [Q8TAT6-1] DR ProteomicsDB; 73918; -. [Q8TAT6-2] DR Pumba; Q8TAT6; -. DR Antibodypedia; 10070; 165 antibodies from 28 providers. DR DNASU; 55666; -. DR Ensembl; ENST00000331134.11; ENSP00000331487.5; ENSG00000182446.15. [Q8TAT6-1] DR Ensembl; ENST00000374747.9; ENSP00000363879.5; ENSG00000182446.15. [Q8TAT6-2] DR GeneID; 55666; -. DR KEGG; hsa:55666; -. DR MANE-Select; ENST00000331134.11; ENSP00000331487.5; NM_017921.4; NP_060391.2. DR UCSC; uc002kat.5; human. [Q8TAT6-1] DR AGR; HGNC:18261; -. DR CTD; 55666; -. DR DisGeNET; 55666; -. DR GeneCards; NPLOC4; -. DR HGNC; HGNC:18261; NPLOC4. DR HPA; ENSG00000182446; Tissue enhanced (skeletal). DR MIM; 606590; gene. DR neXtProt; NX_Q8TAT6; -. DR OpenTargets; ENSG00000182446; -. DR PharmGKB; PA143485558; -. DR VEuPathDB; HostDB:ENSG00000182446; -. DR eggNOG; KOG2834; Eukaryota. DR GeneTree; ENSGT00390000018731; -. DR HOGENOM; CLU_017172_2_0_1; -. DR InParanoid; Q8TAT6; -. DR OMA; KWSRTGR; -. DR OrthoDB; 5400828at2759; -. DR PhylomeDB; Q8TAT6; -. DR TreeFam; TF314173; -. DR PathwayCommons; Q8TAT6; -. DR Reactome; R-HSA-110320; Translesion Synthesis by POLH. DR Reactome; R-HSA-8951664; Neddylation. DR Reactome; R-HSA-9755511; KEAP1-NFE2L2 pathway. DR SignaLink; Q8TAT6; -. DR SIGNOR; Q8TAT6; -. DR UniPathway; UPA00144; -. DR BioGRID-ORCS; 55666; 808 hits in 1156 CRISPR screens. DR ChiTaRS; NPLOC4; human. DR GeneWiki; NPLOC4; -. DR GenomeRNAi; 55666; -. DR Pharos; Q8TAT6; Tbio. DR PRO; PR:Q8TAT6; -. DR Proteomes; UP000005640; Chromosome 17. DR RNAct; Q8TAT6; Protein. DR Bgee; ENSG00000182446; Expressed in gastrocnemius and 196 other cell types or tissues. DR ExpressionAtlas; Q8TAT6; baseline and differential. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005783; C:endoplasmic reticulum; ISS:HGNC-UCL. DR GO; GO:0042175; C:nuclear outer membrane-endoplasmic reticulum membrane network; ISS:HGNC-UCL. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR GO; GO:0005634; C:nucleus; HDA:UniProtKB. DR GO; GO:0036501; C:UFD1-NPL4 complex; IPI:ParkinsonsUK-UCL. DR GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:UniProtKB. DR GO; GO:0051117; F:ATPase binding; IEA:Ensembl. DR GO; GO:0036435; F:K48-linked polyubiquitin modification-dependent protein binding; IEA:Ensembl. DR GO; GO:0070530; F:K63-linked polyubiquitin modification-dependent protein binding; IEA:Ensembl. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl. DR GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central. DR GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central. DR GO; GO:0007030; P:Golgi organization; ISS:HGNC-UCL. DR GO; GO:0039536; P:negative regulation of RIG-I signaling pathway; IMP:UniProtKB. DR GO; GO:0032480; P:negative regulation of type I interferon production; IMP:UniProtKB. DR GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL. DR GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; ISO:ComplexPortal. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB. DR CDD; cd08061; MPN_NPL4; 1. DR Gene3D; 3.40.140.10; Cytidine Deaminase, domain 2; 1. DR Gene3D; 2.30.30.380; Zn-finger domain of Sec23/24; 1. DR InterPro; IPR037518; MPN. DR InterPro; IPR016563; Npl4. DR InterPro; IPR007717; NPL4_C. DR InterPro; IPR024682; Npl4_Ub-like_dom. DR InterPro; IPR007716; NPL4_Zn-bd_put. DR InterPro; IPR029071; Ubiquitin-like_domsf. DR InterPro; IPR001876; Znf_RanBP2. DR InterPro; IPR036443; Znf_RanBP2_sf. DR PANTHER; PTHR12710; NUCLEAR PROTEIN LOCALIZATION 4; 1. DR PANTHER; PTHR12710:SF0; NUCLEAR PROTEIN LOCALIZATION PROTEIN 4 HOMOLOG; 1. DR Pfam; PF05021; NPL4; 1. DR Pfam; PF11543; UN_NPL4; 1. DR Pfam; PF05020; zf-NPL4; 1. DR PIRSF; PIRSF010052; Polyub_prc_Npl4; 1. DR SMART; SM00547; ZnF_RBZ; 1. DR SUPFAM; SSF90209; Ran binding protein zinc finger-like; 1. DR SUPFAM; SSF54236; Ubiquitin-like; 1. DR PROSITE; PS50249; MPN; 1. DR PROSITE; PS01358; ZF_RANBP2_1; 1. DR PROSITE; PS50199; ZF_RANBP2_2; 1. DR Genevisible; Q8TAT6; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; Chaperone; Cytoplasm; KW Direct protein sequencing; Endoplasmic reticulum; Metal-binding; Nucleus; KW Reference proteome; Ubl conjugation pathway; Zinc; Zinc-finger. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:12665801, FT ECO:0007744|PubMed:19413330" FT CHAIN 2..608 FT /note="Nuclear protein localization protein 4 homolog" FT /id="PRO_0000057941" FT DOMAIN 226..363 FT /note="MPN" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01182" FT ZN_FING 580..608 FT /note="RanBP2-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00322" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:19413330" FT MOD_RES 179 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P60670" FT VAR_SEQ 558..608 FT /note="TVGGQLPGLHEYGAVGGSTHTATAAMWACQHCTFMNQPGTGHCEMCSLPRT FT -> EYPHPLPRHPVAGAGEQPTLHSSPLPVVPWIPHPAASWQVPSAMQRVETRPPCQAR FT GRLR (in isoform 2)" FT /evidence="ECO:0000303|PubMed:10819331" FT /id="VSP_009789" FT MUTAGEN 6..8 FT /note="IIR->AIA: Abolished interaction with VCP; when FT associated with A-17 and A-50." FT /evidence="ECO:0000269|PubMed:26471729" FT MUTAGEN 17 FT /note="R->A: Abolished interaction with VCP; when FT associated with 6-A--A-8 and A-50." FT /evidence="ECO:0000269|PubMed:26471729" FT MUTAGEN 50 FT /note="R->A: Abolished interaction with VCP; when FT associated with 6-A--A-8 and A-17." FT /evidence="ECO:0000269|PubMed:26471729" FT CONFLICT 246 FT /note="N -> S (in Ref. 2; BAB14499)" FT /evidence="ECO:0000305" FT CONFLICT 248 FT /note="H -> Q (in Ref. 2; BAA91314)" FT /evidence="ECO:0000305" FT CONFLICT 573 FT /note="G -> E (in Ref. 2; BAA91314)" FT /evidence="ECO:0000305" FT CONFLICT 592 FT /note="M -> V (in Ref. 2; BAB14499)" FT /evidence="ECO:0000305" FT HELIX 109..114 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 127..129 FT /evidence="ECO:0007829|PDB:7WWP" FT TURN 139..141 FT /evidence="ECO:0007829|PDB:7WWP" FT HELIX 151..153 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 155..157 FT /evidence="ECO:0007829|PDB:7WWP" FT STRAND 160..163 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 164..169 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 213..215 FT /evidence="ECO:0007829|PDB:7WWP" FT STRAND 220..222 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 225..230 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 231..244 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 249..259 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 265..274 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 277..281 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 284..287 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 293..302 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 306..313 FT /evidence="ECO:0007829|PDB:7WWQ" FT TURN 320..323 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 338..350 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 351..354 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 356..358 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 361..365 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 368..374 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 378..387 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 389..396 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 400..403 FT /evidence="ECO:0007829|PDB:7WWP" FT STRAND 409..412 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 424..427 FT /evidence="ECO:0007829|PDB:7WWP" FT STRAND 441..444 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 445..447 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 449..455 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 477..479 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 485..494 FT /evidence="ECO:0007829|PDB:7WWQ" FT TURN 495..497 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 500..504 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 507..515 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 517..519 FT /evidence="ECO:0007829|PDB:7WWQ" FT STRAND 522..524 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 526..533 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 537..544 FT /evidence="ECO:0007829|PDB:7WWQ" FT HELIX 547..556 FT /evidence="ECO:0007829|PDB:7WWQ" SQ SEQUENCE 608 AA; 68120 MW; 6ED6A0145F15C01D CRC64; MAESIIIRVQ SPDGVKRITA TKRETAATFL KKVAKEFGFQ NNGFSVYINR NKTGEITASS NKSLNLLKIK HGDLLFLFPS SLAGPSSEME TSVPPGFKVF GAPNVVEDEI DQYLSKQDGK IYRSRDPQLC RHGPLGKCVH CVPLEPFDED YLNHLEPPVK HMSFHAYIRK LTGGADKGKF VALENISCKI KSGCEGHLPW PNGICTKCQP SAITLNRQKY RHVDNIMFEN HTVADRFLDF WRKTGNQHFG YLYGRYTEHK DIPLGIRAEV AAIYEPPQIG TQNSLELLED PKAEVVDEIA AKLGLRKVGW IFTDLVSEDT RKGTVRYSRN KDTYFLSSEE CITAGDFQNK HPNMCRLSPD GHFGSKFVTA VATGGPDNQV HFEGYQVSNQ CMALVRDECL LPCKDAPELG YAKESSSEQY VPDVFYKDVD KFGNEITQLA RPLPVEYLII DITTTFPKDP VYTFSISQNP FPIENRDVLG ETQDFHSLAT YLSQNTSSVF LDTISDFHLL LFLVTNEVMP LQDSISLLLE AVRTRNEELA QTWKRSEQWA TIEQLCSTVG GQLPGLHEYG AVGGSTHTAT AAMWACQHCT FMNQPGTGHC EMCSLPRT //